VenetoclaxVenetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Sponsor:

PedAL BCU, LLC

Code:

NCT05183035

Conditions

Acute Myeloid Leukemia

Eligibility Criteria

Sex: All

Age: 0 - 21

Healthy Volunteers: Not accepted

Interventions

Fludarabine

Cytarabine

Gemtuzumab Ozogamicin

Azacitidine

Venetoclax

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-24. This information was provided to ClinicalTrials.gov by PedAL BCU, LLC on 2026-05-19.